These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27556696)

  • 21. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
    Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA NEAT1 Enhances Glioma Progression via Regulating the miR-128-3p/ITGA5 Axis.
    Chen J; Wang H; Wang J; Niu W; Deng C; Zhou M
    Mol Neurobiol; 2021 Oct; 58(10):5163-5177. PubMed ID: 34263426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long Noncoding RNA NEAT1 Suppresses Proliferation and Promotes Apoptosis of Glioma Cells Via Downregulating MiR-92b.
    Liu D; Zou Z; Li G; Pan P; Liang G
    Cancer Control; 2020; 27(1):1073274819897977. PubMed ID: 31933377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132.
    Zhou K; Zhang C; Yao H; Zhang X; Zhou Y; Che Y; Huang Y
    Mol Cancer; 2018 Jul; 17(1):105. PubMed ID: 30053878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Mu M; Niu W; Zhang X; Hu S; Niu C
    Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA NEAT1 regulates permeability of the blood-tumor barrier via miR-181d-5p-mediated expression changes in ZO-1, occludin, and claudin-5.
    Guo J; Cai H; Zheng J; Liu X; Liu Y; Ma J; Que Z; Gong W; Gao Y; Tao W; Xue Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2240-2254. PubMed ID: 28185956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA NEAT1 promotes progression of glioma as a ceRNA by sponging miR-185-5p to stimulate DNMT1/mTOR signaling.
    Yu H; Xu A; Wu B; Wang M; Chen Z
    J Cell Physiol; 2021 Jan; 236(1):121-130. PubMed ID: 32803763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA NEAT1 promotes the growth of gastric cancer cells by regulating miR-497-5p/PIK3R1 axis.
    Xia TF; Chen J; Wu K; Zhang J; Yan Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6914-6926. PubMed ID: 31486491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Noncoding RNA
    Yao L; Chen L; Zhou H; Duan F; Wang L; Zhang Y
    Cancer Biother Radiopharm; 2022 Oct; 37(8):636-649. PubMed ID: 32833504
    [No Abstract]   [Full Text] [Related]  

  • 30. MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5.
    Wang H; Tan L; Dong X; Liu L; Jiang Q; Li H; Shi J; Yang X; Dai X; Qian Z; Dong J
    Aging (Albany NY); 2020 Jul; 12(13):13647-13667. PubMed ID: 32632040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
    Zhao L; Bi M; Zhang H; Shi M
    Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
    [No Abstract]   [Full Text] [Related]  

  • 32. Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16.
    Chen X; Li D; Gao Y; Tang W; Iw L; Cao Y; Hao B
    Cell Physiol Biochem; 2018; 46(3):1055-1064. PubMed ID: 29669323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of NEAT1 repressed the malignant progression of glioma through sponging miR-107 and inhibiting CDK14.
    Zhen Y; Nan Y; Guo S; Zhang L; Li G; Yue S; Liu X
    J Cell Physiol; 2019 Jul; 234(7):10671-10679. PubMed ID: 30480816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer by Targeting ZEB1 via miR-448.
    Wu H; Dong D; Wang J; Yin S; Gong Y; Yang C; Bai Y; Wang J; Du Y
    Technol Cancer Res Treat; 2022; 21():15330338221085348. PubMed ID: 35695254
    [No Abstract]   [Full Text] [Related]  

  • 35. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.
    Li O; Jiang B; Yi WM; Zhang Y; Yang PZ; Guo C; Sun ZP; Peng C
    Kaohsiung J Med Sci; 2021 May; 37(5):379-391. PubMed ID: 33502823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Noncoding RNA HOTAIRM1 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells Through Regulation of HOX Gene Expression.
    Xia H; Liu Y; Wang Z; Zhang W; Qi M; Qi B; Jiang X
    Neurotherapeutics; 2020 Apr; 17(2):754-764. PubMed ID: 31691127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p.
    Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F
    Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZEB1 causes the production of hsa-microRNA-99b/let-7e/microRNA-125a cluster and promotes invasion of liver cancer cells.
    Wang XF; Liu JY; Li JL; Wang FZ; Sun BL
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1468-1475. PubMed ID: 30840268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CENPA facilitates glioma stem cell stemness and suppress ferroptosis to accelerate glioblastoma multiforme progression by promoting GBP2 transcription.
    Li C; Jing J; Wang Y; Jiang H
    Pathol Res Pract; 2024 Aug; 260():155438. PubMed ID: 38964117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINC00467 knockdown repressed cell proliferation but stimulated cell apoptosis in glioblastoma via miR-339-3p/IP6K2 axis.
    Liang R; Tang Y
    Cancer Biomark; 2020; 28(2):169-180. PubMed ID: 32176627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.